相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism
Po-Han Chen et al.
CELL DEATH AND DIFFERENTIATION (2020)
Hippo pathway effectors YAP/TAZ as novel determinants of ferroptosis
Wen-Hsuan Yang et al.
MOLECULAR & CELLULAR ONCOLOGY (2020)
The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma
Wen-Hsuan Yang et al.
CELL REPORTS (2019)
RIPK1 and Caspase-8 Ensure Chromosome Stability Independently of Their Role in Cell Death and Inflammation
Gianmaria Liccardi et al.
MOLECULAR CELL (2019)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor et al.
CANCER CELL (2018)
CoA synthase regulates mitotic fidelity via CBP-mediated acetylation
Chao-Chieh Lin et al.
NATURE COMMUNICATIONS (2018)
Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer
Nathaniel W. Mabe et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth
Shiro L. Cramer et al.
NATURE MEDICINE (2017)
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling (vol 36, pg 4235, 2017)
X. Tang et al.
ONCOGENE (2017)
RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function
Kay Hanggi et al.
CELL DEATH & DISEASE (2017)
2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter
Zhentao Yang et al.
CELL REPORTS (2017)
Glycosylation of KEAP1 links nutrient sensing to redox stress signaling
Po-Han Chen et al.
EMBO JOURNAL (2017)
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells
Ulrike Hoeckendorf et al.
CANCER CELL (2016)
Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas
Xiaohu Tang et al.
CANCER RESEARCH (2016)
RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4
Malek Najjar et al.
IMMUNITY (2016)
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
Lena Seifert et al.
NATURE (2016)
Evaluation of RIP1K and RIP3K expressions in the malignant and benign breast tumors
Fatemeh Karami-Tehrani et al.
TUMOR BIOLOGY (2016)
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics
Gi-Bang Koo et al.
CELL RESEARCH (2015)
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Silvana Konermann et al.
NATURE (2015)
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Nader Yatim et al.
SCIENCE (2015)
Clinical and molecular complexity of breast cancer metastases
Siker Kimbung et al.
SEMINARS IN CANCER BIOLOGY (2015)
RIPK1 and RIPK3: critical regulators of inflammation and cell death
Kim Newton
TRENDS IN CELL BIOLOGY (2015)
Aneuploidy and chromosomal instability in cancer: a jackpot to chaos
Maybelline Giam et al.
CELL DIVISION (2015)
Absence of RIPK3 predicts necroptosis resistance in malignant melanoma
P. Geserick et al.
CELL DEATH & DISEASE (2015)
Comprehensive Profiling of Amino Acid Response Uncovers Unique Methionine-Deprived Response Dependent on Intact Creatine Biosynthesis
Xiaohu Tang et al.
PLOS GENETICS (2015)
Novel genes associated with lymph node metastasis in triple negative breast cancer
Andrea Mathe et al.
SCIENTIFIC REPORTS (2015)
Ceramide Kinase Promotes Tumor Cell Survival and Mammary Tumor Recurrence
Ania W. Payne et al.
CANCER RESEARCH (2014)
Cytokinesis Failure Triggers Hippo Tumor Suppressor Pathway Activation
Neil J. Ganem et al.
CELL (2014)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
The Necroptosis Adaptor RIPK3 Promotes Injury-Induced Cytokine Expression and Tissue Repair
Kenta Moriwaki et al.
IMMUNITY (2014)
Ferrostatins Inhibit Oxidative Lipid Damage and Cell Death in Diverse Disease Models
Rachid Skouta et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Screening with a Novel Cell-Based Assay for TAZ Activators Identifies a Compound That Enhances Myogenesis in C2C12 Cells and Facilitates Muscle Repair in a Muscle Injury Model
Zeyu Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3
Huayi Wang et al.
MOLECULAR CELL (2014)
Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy
James V. Alvarez et al.
CANCER CELL (2013)
xCT Inhibition Depletes CD44v-Expressing Tumor Cells That Are Resistant to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma
Momoko Yoshikawa et al.
CANCER RESEARCH (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Liming Sun et al.
CELL (2012)
Regulation of glutathione synthesis
Shelly C. Lu
MOLECULAR ASPECTS OF MEDICINE (2009)
Breast cancer metastases are molecularly distinct from their primary tumors
M. Vecchi et al.
ONCOGENE (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Redox regulation of hepatocyte apoptosis
Carmen Garcia-Ruiz et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5
Ke Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc- protects from oxidative glutamate toxicity
Jan Lewerenz et al.
JOURNAL OF NEUROCHEMISTRY (2006)
The transcriptional repressor snail promotes mammary tumor recurrence
SE Moody et al.
CANCER CELL (2005)
Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation
RB Boxer et al.
CANCER CELL (2004)
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells
S Dolma et al.
CANCER CELL (2003)
Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis
EJ Gunther et al.
GENES & DEVELOPMENT (2003)
Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis
SE Moody et al.
CANCER CELL (2002)
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc- cystine transporter:: a new action for an old drug
PW Gout et al.
LEUKEMIA (2001)
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations
CM D'Cruz et al.
NATURE MEDICINE (2001)
分享论文
